Literature DB >> 15379436

A pharmacokinetic comparison of meloxicam and ketoprofen following oral administration to healthy dogs.

L Montoya1, L Ambros, V Kreil, R Bonafine, G Albarellos, R Hallu, A Soraci.   

Abstract

Ketoprofen (KTP) and meloxicam (MLX) are non-steroidal anti-inflamatory drugs used extensively in veterinary medicine. The pharmacokinetics of these drugs were studied in eight dogs following a single oral dose of 1 mg/kg of KTP as a racemate or 0.2 mg/kg of MLX. The concentrations of the drugs in plasma were determined by high-performance liquid chromatography (HPLC). There were differences between the disposition curves of the KTP enantiomers, confirming that the pharmacokinetics of KTP is enantioselective. (S)-(+)-KTP was the predominant enantiomer; the S:R ratio in the plasma increased from 2.58 +/- 0.38 at 15 min to 5.72 +/- 2.35 at 1 h. The area under the concentration time curve (AUC) of (S)-(+)-KTP was approximately 6 times greater than that of (R)-(-)-KTP. The mean (+/- SD) pharmacokinetic parameters for (S)-(+)-KTP were characterized as Tmax = 0.76 +/- 0.19 h, Cmax = 2.02 +/- 0.41 microg/ml, t1/2el = 1.65 +/- 0.48 h, AUC = 6.06 +/- 1.16 microg.h/ml, Vd/F = 0.39 +/- 0.07 L/kg, Cl/F = 170 +/- 39 ml/(kg.h). The mean (+/- SD) pharmacokinetic parameters of MLX were Tmax = 8.5 +/- 1.91 h, Cmax = 0.82 +/- 0.29 microg/ml, t1/2lambda(z) = 12.13 +/- 2.15 h, AUCinf = 15.41 +/- 1.24 microg.h/ml, Vd/F = 0.23 +/- 0.03 L/ kg, and Cl/F = 10 +/- 1.4 ml/(kg.h). Our results indicate significant pharmacokinetic differences between MLX and KTP after therapeutic doses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379436     DOI: 10.1023/b:verc.0000034995.81994.49

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  39 in total

1.  Pharmacokinetics of meloxicam in animals and the relevance to humans.

Authors:  U Busch; J Schmid; G Heinzel; H Schmaus; J Baierl; C Huber; W Roth
Journal:  Drug Metab Dispos       Date:  1998-06       Impact factor: 3.922

2.  Chiral inversion of R(-) fenoprofen and ketoprofen enantiomers in cats.

Authors:  E Castro; A Soraci; F Fogel; O Tapia
Journal:  J Vet Pharmacol Ther       Date:  2000-10       Impact factor: 1.786

3.  High-performance liquid chromatographic assay of ketoprofen enantiomers in human plasma and urine.

Authors:  R T Foster; F Jamali
Journal:  J Chromatogr       Date:  1987-05-15

4.  Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations.

Authors:  K Yamaoka; T Nakagawa; T Uno
Journal:  J Pharmacokinet Biopharm       Date:  1978-04

5.  Chiral inversion of (R)-ketoprofen: influence of age and differing physiological status in dairy cattle.

Authors:  L Igarza; A Soraci; N Auza; H Zeballos
Journal:  Vet Res Commun       Date:  2002-01       Impact factor: 2.459

6.  Meloxicam oral suspension: a treatment alternative to solid meloxicam formulations.

Authors:  G Hanft; D Türck; S Scheuerer; R Sigmund
Journal:  Inflamm Res       Date:  2001-03       Impact factor: 4.575

7.  In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats.

Authors:  C Brideau; C Van Staden; C C Chan
Journal:  Am J Vet Res       Date:  2001-11       Impact factor: 1.156

8.  [Comparative enantioselectivity of the disposition of two non-steroidal anti-inflammatory agents, ketoprofen and carprofen, in man and animals].

Authors:  P Delatour; E Benoit; M Bourdin; M Gobron; F Moysan
Journal:  Bull Acad Natl Med       Date:  1993-03       Impact factor: 0.144

Review 9.  The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences.

Authors:  J Caldwell; A J Hutt; S Fournel-Gigleux
Journal:  Biochem Pharmacol       Date:  1988-01-01       Impact factor: 5.858

10.  Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis.

Authors:  J Dequeker; C Hawkey; A Kahan; K Steinbrück; C Alegre; E Baumelou; B Bégaud; H Isomäki; G Littlejohn; J Mau; S Papazoglou
Journal:  Br J Rheumatol       Date:  1998-09
View more
  13 in total

1.  Pharmacokinetics of 3 formulations of meloxicam in cynomolgus macaques (Macaca fascicularis).

Authors:  Cassondra Bauer; Patrice Frost; Stephen Kirschner
Journal:  J Am Assoc Lab Anim Sci       Date:  2014-09       Impact factor: 1.232

2.  Aqueous stability and oral pharmacokinetics of meloxicam and carprofen in male C57BL/6 mice.

Authors:  Joelle C Ingrao; Ron Johnson; Elizabeth Tor; Yu Gu; Marcus Litman; Patricia V Turner
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-09       Impact factor: 1.232

3.  Pharmacokinetics of Single-dose Subcutaneous Meloxicam Injections in Black-tailed Prairie Dogs (Cynomys ludovicianus).

Authors:  Thomas L Wright; David Eshar; Christina McCullough; Matt Warner; Butch Kukanich
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-09-01       Impact factor: 1.232

4.  Bioavailability and pharmacokinetics of oral meloxicam in llamas.

Authors:  Amanda J Kreuder; Johann F Coetzee; Larry W Wulf; Jennifer A Schleining; Butch KuKanich; Lori L Layman; Paul J Plummer
Journal:  BMC Vet Res       Date:  2012-06-21       Impact factor: 2.741

5.  Removing the threat of diclofenac to critically endangered Asian vultures.

Authors:  Gerry Swan; Vinasan Naidoo; Richard Cuthbert; Rhys E Green; Deborah J Pain; Devendra Swarup; Vibhu Prakash; Mark Taggart; Lizette Bekker; Devojit Das; Jörg Diekmann; Maria Diekmann; Elmarié Killian; Andy Meharg; Ramesh Chandra Patra; Mohini Saini; Kerri Wolter
Journal:  PLoS Biol       Date:  2006-01-31       Impact factor: 8.029

6.  Meloxicam decreases the migration and invasion of CF41.Mg canine mammary carcinoma cells.

Authors:  María P Iturriaga; Rodolfo Paredes; Jose I Arias; Cristian G Torres
Journal:  Oncol Lett       Date:  2017-06-16       Impact factor: 2.967

7.  Development of Tizanidine HCl-Meloxicam loaded mucoadhesive buccal films: In-vitro and in-vivo evaluation.

Authors:  Muhammad Zaman; Muhammad Hanif; Zaib Ali Shaheryar
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

8.  Plasma pharmacokinetic profile and efficacy of meloxicam administered subcutaneously and intramuscularly to sheep.

Authors:  Alyssa N Woodland; Dominique Van der Saag; Benjamin Kimble; Peter J White; Merran Govendir; Sabrina Lomax
Journal:  PLoS One       Date:  2019-04-24       Impact factor: 3.240

9.  Multi-Injection Pharmacokinetics of Meloxicam in Kemp's Ridley (Lepidochelys kempii) and Green (Chelonia mydas) Sea Turtles after Subcutaneous Administration.

Authors:  Terry M Norton; Tonya Clauss; Rachel Overmeyer; Stephanie Stowell; Michelle Kaylor; Sherry Cox
Journal:  Animals (Basel)       Date:  2021-12-10       Impact factor: 2.752

10.  Pharmacokinetic Evaluation of a Novel Transdermal Ketoprofen Formulation in Healthy Dogs.

Authors:  Halley Gora Ravuri; Nana Satake; Alexandra Balmanno; Jazmine Skinner; Samantha Kempster; Paul C Mills
Journal:  Pharmaceutics       Date:  2022-03-15       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.